Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Ole B. Suhr, Yeşim Parman et al.|New England Journal of Medicine|2018Cited by 2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D. Gillmore, Philip N. Hawkins, Matthew J. Maurer et al.|Circulation|2016Cited by 2k
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D. Benson, Teresa Coelho, Márcia Waddington‐Cruz et al.|New England Journal of Medicine|2018Cited by 1.4k
Repurposing Diflunisal for Familial Amyloid PolyneuropathyJohn L. Berk, P. James B. Dyck, Ole B. Suhr et al.|JAMA|2013Cited by 701
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year StudyMartha Skinner, Daniel G. Wright, Vaishali Sanchorawala et al.|Annals of Internal Medicine|2004Cited by 615